Biotransformation of benzo[a]pyrene in Ahr knockout mice is dependent on time and route of exposure.
Benzo[a]pyrene (BP) is an ubiquitous environmental pollutant with potent mutagenic and carcinogenic properties. The Ah receptor (Ahr) is important in the metabolic activation of BP and is therefore central to BP-induced carcinogenesis. Although Ahr(-/-) mice are refractory to BP-induced carcinogenesis, higher levels of BP-DNA and -protein adducts were formed in them than in wild-type mice. These results indicated the presence of an Ahr-independent and/or a slower biotransformation of BP in Ahr knockout mice. To address this issue further, we have now performed a time-course experiment, with mice receiving a single oral dose of BP (100 mg/kg). Wild-type mice have an effective clearance of BP metabolites, mainly through 3-hydroxybenzo[a]pyrene and 9-hydroxybenzo[a]pyrene in the feces with reduced levels of DNA and protein adducts in the examined tissues. On the other hand, the Ahr(-/-) mice appear to have a lower metabolic clearance of BP resulting in increased levels of DNA and protein adducts and of unmetabolized BP. In addition, we have performed an administration route experiment and found that skin-exposed Ahr(-/-) mice showed lower levels of protein adducts along with markedly reduced P450 1B1 expression, but only in the exposed area, as compared with the wild-type mice. In addition, the systemic uptake of BP is increased in the Ahr(-/-) mice as compared with the wild-type mice. Hence, the lack of a functional Ah receptor results in an Ahr-independent biotransformation of BP with a slower clearance of BP and higher levels of DNA and protein adducts, but the distribution and levels of BP and BP-protein adducts are clearly dependent on the route of exposure.
Sagredo
Carlos
C
Section for Toxicology, The National Institute of Occupational Health, P.O. Box 8149 Dep., N-0033 Oslo, Norway. carlos.sagredo@stami.no
Mollerup
Steen
S
Cole
Kathleen J
KJ
Phillips
David H
DH
Uppstad
Heidi
H
Øvrebø
Steinar
S
D000818:Animals; D001564:Benzo(a)pyrene / Q000008:administration & dosage / Q000378:metabolism*; D001579:Benzopyrene Hydroxylase / Q000378:metabolism; D001711:Biotransformation / Q000235:genetics; D002273:Carcinogens / Q000008:administration & dosage / Q000378:metabolism*; D019363:Cytochrome P-450 CYP1A1 / Q000235:genetics / Q000378:metabolism; D018736:DNA Adducts / Q000032:analysis; D007700:Kinetics; D051379:Mice; D018345:Mice, Knockout; D018336:Receptors, Aryl Hydrocarbon / Q000235:genetics*
D002273:Carcinogens; D018736:DNA Adducts; D018336:Receptors, Aryl Hydrocarbon; D001564:Benzo(a)pyrene; D001579:Benzopyrene Hydroxylase; D019363:Cytochrome P-450 CYP1A1